| Primary |
| Product Used For Unknown Indication |
18.2% |
| Drug Use For Unknown Indication |
12.5% |
| Asthma |
6.8% |
| Dry Skin |
5.7% |
| Hypertension |
5.7% |
| Atopy |
4.5% |
| Herpes Zoster |
4.5% |
| Hyperlipidaemia |
4.5% |
| Pneumonia Mycoplasmal |
4.5% |
| Rheumatoid Arthritis |
4.5% |
| Dermatitis Atopic |
3.4% |
| Eczema |
3.4% |
| Eustachian Tube Obstruction |
3.4% |
| Myocardial Ischaemia |
3.4% |
| Skin Disorder |
3.4% |
| Cardiac Failure |
2.3% |
| Cutaneous Amyloidosis |
2.3% |
| Empyema |
2.3% |
| Enchondroma |
2.3% |
| Eustachian Tube Stenosis |
2.3% |
|
| Toxic Skin Eruption |
13.3% |
| Liver Disorder |
10.0% |
| Platelet Count Decreased |
10.0% |
| Convulsion |
6.7% |
| Dizziness |
6.7% |
| Myoclonus |
6.7% |
| Abortion Induced |
3.3% |
| Angina Pectoris |
3.3% |
| Autoimmune Hepatitis |
3.3% |
| Drug Eruption |
3.3% |
| Drug Hypersensitivity |
3.3% |
| Drug-induced Liver Injury |
3.3% |
| Electrocardiogram Qt Prolonged |
3.3% |
| Eosinophilia |
3.3% |
| Extrapyramidal Disorder |
3.3% |
| Febrile Convulsion |
3.3% |
| Feeling Abnormal |
3.3% |
| Gastrointestinal Haemorrhage |
3.3% |
| Hepatitis |
3.3% |
| Lacrimation Increased |
3.3% |
|
| Secondary |
| Product Used For Unknown Indication |
28.0% |
| Nasopharyngitis |
9.1% |
| Hypertension |
8.4% |
| Cardiac Failure |
7.7% |
| Rheumatoid Arthritis |
4.9% |
| Asthma |
4.2% |
| Insomnia |
4.2% |
| Pulmonary Tuberculosis |
4.2% |
| Herpes Zoster |
3.5% |
| Analgesic Intervention Supportive Therapy |
2.8% |
| Atopy |
2.8% |
| Disseminated Tuberculosis |
2.8% |
| Dry Skin |
2.8% |
| Psoriasis |
2.8% |
| Cardiac Failure Chronic |
2.1% |
| Constipation |
2.1% |
| Contusion |
2.1% |
| Hepatitis C |
2.1% |
| Pustular Psoriasis |
2.1% |
| Analgesic Asthma Syndrome |
1.4% |
|
| Liver Disorder |
13.8% |
| Alanine Aminotransferase Increased |
6.9% |
| Apnoeic Attack |
6.9% |
| Cholestasis |
6.9% |
| Hepatic Function Abnormal |
6.9% |
| Loss Of Consciousness |
6.9% |
| Toxic Skin Eruption |
6.9% |
| Abnormal Behaviour |
3.4% |
| Aspartate Aminotransferase Increased |
3.4% |
| Blood Alkaline Phosphatase Increased |
3.4% |
| Blood Lactate Dehydrogenase Increased |
3.4% |
| Brain Natriuretic Peptide Increased |
3.4% |
| Cardiac Failure |
3.4% |
| Drug Eruption |
3.4% |
| Drug Exposure During Pregnancy |
3.4% |
| Drug Hypersensitivity |
3.4% |
| Drug Ineffective |
3.4% |
| Erythema |
3.4% |
| Gingival Bleeding |
3.4% |
| Jaundice |
3.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
18.3% |
| Hepatitis C |
12.1% |
| Prophylaxis |
10.5% |
| Psoriasis |
9.3% |
| Hypertension |
6.7% |
| Rheumatoid Arthritis |
6.7% |
| Constipation |
3.7% |
| Graft Versus Host Disease |
3.6% |
| Asthma |
3.6% |
| Supportive Care |
3.5% |
| Insomnia |
2.9% |
| Rhinitis Allergic |
2.9% |
| Prophylaxis Against Graft Versus Host Disease |
2.4% |
| Depression |
2.2% |
| Adult T-cell Lymphoma/leukaemia |
2.0% |
| Bronchitis |
2.0% |
| Gastritis |
2.0% |
| Diabetes Mellitus |
1.9% |
| Crohn's Disease |
1.9% |
| Antifungal Prophylaxis |
1.8% |
|
| White Blood Cell Count Increased |
9.7% |
| Hepatic Function Abnormal |
8.2% |
| Neutrophil Count Decreased |
6.7% |
| Haemoglobin Decreased |
6.0% |
| Pyrexia |
6.0% |
| Sepsis |
6.0% |
| Rhabdomyolysis |
5.2% |
| Death |
4.5% |
| Intraocular Pressure Increased |
4.5% |
| Renal Disorder |
4.5% |
| Vomiting |
4.5% |
| White Blood Cell Count Decreased |
4.5% |
| Drug Eruption |
3.7% |
| Erythema |
3.7% |
| Liver Disorder |
3.7% |
| Loss Of Consciousness |
3.7% |
| Nausea |
3.7% |
| Neutropenia |
3.7% |
| Platelet Count Decreased |
3.7% |
| Rash |
3.7% |
|
| Interacting |
| Product Used For Unknown Indication |
36.4% |
| Hypertension |
18.2% |
| Gastrooesophageal Reflux Disease |
9.1% |
| Ventricular Extrasystoles |
9.1% |
| Atrial Fibrillation |
4.5% |
| Back Pain |
4.5% |
| Constipation |
4.5% |
| Oedema |
4.5% |
| Pain |
4.5% |
| Seasonal Allergy |
4.5% |
|
| Myalgia |
42.9% |
| Dyspnoea |
28.6% |
| Cerebral Infarction |
14.3% |
| Drug Prescribing Error |
14.3% |
|
